-
-
Longer Lasting Smallpox Immunity?; Is There a Rabid Bat in Your Belfry?; Nosocomial C difficile: Way Common
-
In this feature, brief items, primarily gleaned from abstracts or articles in journals and other resources not commonly perused by most US infectious disease physicians, will be presented, usually without comment.
-
The 10-page human subjects consent form proposed for the Dryvax vaccination study of children, ages 2 to 5, has a number of flaws, according to the IRBs and experts who have reviewed the study proposal and consent form.
-
Once a final decision is made regarding some proposed research involving very young children and an older smallpox vaccine, there could be long-term repercussions for IRBs nationwide.
-
The proposal for the study, A Multicenter, Randomized Dose Response Study of the Safety, Clinical and Immune Responses of DryVax Vaccine Administered to Children 2 to 5 Years of Age, provides the following details.
-
Thomson American Health Consultants is offering "Imminent Smallpox Vaccinations in Hospitals: Consequences for You and Your Facility," a 90-minute audio conference Wednesday, Dec. 11, from 2-3:30 p.m., EST.
-
The first stage of smallpox vaccination has begun, even before the doses are released or a final plan formulated. Across the country, hospitals are educating health care workers about smallpox and the vaccinia vaccine.
-
Thomson American Health Consultants is offering "Imminent Smallpox Vaccinations in Hospitals: Consequences for You and Your Facility," a 90-minute audio conference Wednesday, Dec. 11, from 2-3:30 p.m., EST.
-
Hospitals will have considerable leeway to make their own decisions about who and how many health care workers will be immunized for smallpox if the government moves ahead as expected and offers the vaccine to medical personnel.